The journey of tetanus and botulinum neurotoxins in neurons

Trends in Microbiology

Volumn 11, Issue 9, 2003, Pages 431-437

  Lalli, Giovanna ^a   Bohnert, Stephanie ^b   Deinhardt, Katrin ^b   Verastegui, Carole ^b   Schiavo, Giampietro ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CLOSTRIDIUM TOXIN; EXOTOXIN; GLYCOPROTEIN; LIPID; NERVE GROWTH FACTOR; NEUROTOXIN; PROTEIN; PROTEIN P75; PROTEIN SUBUNIT; RECEPTOR PROTEIN; TETANUS TOXIN;

ANAEROBIC BACTERIUM; BINDING AFFINITY; BOTULISM; CARBOXY TERMINAL SEQUENCE; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI; EXOCYTOSIS; FOOD POISONING; GAS GANGRENE; HOST PATHOGEN INTERACTION; MEMBRANE TRANSPORT; NERVE CELL; NERVE FIBER TRANSPORT; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEIN TRANSPORT; RECEPTOR BINDING; REVIEW; TETANUS;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIA; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI; POSIBACTERIA;

EID: 0042825880     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(03)00210-5     Document Type: Review

References (65)

1. Schiavo G., van der Goot F.G. The bacterial toxin toolkit. Nat. Rev. Mol. Cell Biol. 2:2001;530-537.
2. Kahn R.A., et al. Cellular hijacking: a common strategy for microbial infection. Trends Biochem. Sci. 27:2002;308-314.
3. Turton K., et al. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem. Sci. 27:2002;552-558.
4. Foran, P.G. et al. Getting muscles moving again after botulinum toxin: novel therapeutic challenges. Trends Mol. Med. (in press).
5. Schiavo G., et al. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80:2000;717-766.
6. Chen Y.A., Scheller R.H. SNARE-mediated membrane fusion. Nat. Rev. Mol. Cell Biol. 2:2001;98-106.
7. Humeau Y., et al. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie. 82:2000;427-446.
8. Habermann E., Dreyer F. Clostridial neurotoxins: handling and action at the cellular and molecular level. Curr. Top. Microbiol. Immunol. 129:1986;93-179.
9. Habermann E., Weller U. Structure-activity relationships of tetanus in comparison to botulinum toxins. Nistico' G., et al. Eighth International Conference on Tetanus. 1989;43-50 Pythagora Press.
10. Wellhöner H.H. Clostridial toxins and the central nervous system: studies on in situ tissues. Simpson L.L. Botulinum Neurotoxins and Tetanus Toxin. 1989;231-253 Academic Press.
11. Moreno-Lopez B., et al. Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: alterations of the discharge pattern. Neuroscience. 81:1997;437-455.
12. Lalli G., et al. Functional characterisation of tetanus and botulinum neurotoxins binding domains. J. Cell Sci. 112:1999;2715-2724.
13. C of tetanus toxin. Nat. Struct. Biol. 4:1997;788-792.
14. C fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding. J. Biol. Chem. 275:2000;8889-8894.
15. T1b analogue suggests cross-linking between ganglioside receptors and the toxin. J. Biol. Chem. 276:2001;32274-32281.
16. Lacy D.B., et al. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5:1998;898-902.
17. Hanson M.A., Stevens R.C. Cocrystal structure of synaptobrevin II bound to botulinum neurotoxin type B at 2.0 A resolution. Nat. Struct. Biol. 7:2000;687-692.
18. Swaminathan S., Eswaramoorthy S. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol. 7:2000;693-699.
19. Lacy D.B., Stevens R.C. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 291:1999;1091-1104.
20. Louch H.A., et al. Identification of a binding site for ganglioside on the receptor binding domain of tetanus toxin. Biochemistry. 41:2002;13644-13652.
21. CC-domain of tetanus neurotoxin are required for toxicity. J. Mol. Biol. 326:2003;835-847.
22. C fragment: ganglioside binding, cell binding and retrograde axonal transport properties. Mol. Microbiol. 37:2000;1041-1051.
23. Herreros J., et al. C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor. Biochem. J. 347:2000;199-204.
24. Hauri H., et al. Lectins and traffic in the secretory pathway. FEBS Lett. 476:2000;32-37.
25. Williamson L.C., et al. Neuronal sensitivity to tetanus toxin requires gangliosides. J. Biol. Chem. 274:1999;25173-25180.
26. Kitamura M., et al. Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice. J. Neurochem. 73:1999;S64-S64.
27. Montecucco C. How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem. Sci. 11:1986;314-317.
28. D1a. FEBS Lett. 378:1996;253-257.
29. Yowler B.C., et al. Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I. J. Biol. Chem. 277:2002;32815-32819.
30. Ihara H., et al. Sequence of the gene for Clostridium botulinum type B neurotoxin associated with infant botulism, expression of the C-terminal half of heavy chain and its binding activity. Biochim. Biophys. Acta. 1625:2003;19-26.
31. 2+ sensor that triggers exocytosis? Nat. Rev. Mol. Cell Biol. 3:2002;498-508.
32. Herreros J., et al. Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons. J. Neurochem. 74:2000;1941-1950.
33. Herreros J., et al. Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons. Mol. Biol. Cell. 12:2001;2947-2960.
34. Simon P.D., et al. Thy-1 is critical for normal retinal development. Brain Res. Dev. Brain Res. 117:1999;219-223.
35. Leyton L., et al. Thy-1 binds to integrin beta(3) on astrocytes and triggers formation of focal contact sites. Curr. Biol. 11:2001;1028-1038.
36. Munro P., et al. High sensitivity of mouse neuronal cells to tetanus toxin requires a GPI-anchored protein. Biochem. Biophys. Res. Commun. 289:2001;623-629.
37. Pike L.J. Lipid rafts: bringing order to chaos. J. Lipid Res. 44:2003;655-667.
38. Tsui-Pierchala B.A., et al. Lipid rafts in neuronal signaling and function. Trends Neurosci. 25:2002;412-417.
39. Herreros J., Schiavo G. Lipid microdomains are involved in neurospecific binding and internalisation of clostridial neurotoxins. Int. J. Med. Microbiol. 291:2002;447-453.
40. Duncan M.J., et al. Microbial entry through caveolae: variations on a theme. Cell. Microbiol. 4:2002;783-791.
41. Abrami L., et al. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol. 160:2003;321-328.
42. Gil, C. et al. C-terminal fragment of the tetanus toxin heavy chain activates Akt and MEK/ERK signaling pathways in a Trk receptor-dependent manner in cultured cortical neurons. Biochem. J. 373, 613-620.
43. NTR. J. Cell Biol. 156:2002;233-240.
44. Lalli, G. et al. Myosin Va and microtubule-based motors are necessary for fast axonal retrograde transport of tetanus toxin in motor neurons. J. Cell Sci. (in press).
45. Koriazova L.K., Montal M. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat. Struct. Biol. 10:2003;13-18.
46. Ratts R., et al. The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J. Cell Biol. 160:2003;1139-1150.
47. Bakry N.M., et al. Expression of botulinum toxin binding sites in Xenopus oocytes. Infect. Immun. 65:1997;2225-2232.
48. Goldstein L.S., Yang Z. Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu. Rev. Neurosci. 23:2000;39-71.
49. Coen L., et al. Construction of hybrid proteins that migrate retrogradely and transsynaptically into the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 94:1997;9400-9405.
50. Li Y., et al. Recombinant forms of tetanus toxin engineered for examining and exploiting neuronal trafficking pathways. J. Biol. Chem. 276:2001;31394-31401.
51. Vale R.D. The molecular motor toolbox for intracellular transport. Cell. 112:2003;467-480.
52. Hafezparast M., et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 300:2003;808-812.
53. Matteoli M., et al. Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 93:1996;13310-13315.
54. Verderio C., et al. Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes. J. Neurochem. 73:1999;372-379.
55. NTR. Eur. J. Neurosci. 17:2003;673-680.
56. Yan Q., et al. Retrograde transport of nerve growth factor (NGF) in motoneurons of developing rats: assessment of potential neurotrophic effects. Neuron. 1:1988;335-343.
57. Martin J.R., et al. Targeted expression of tetanus toxin: a new tool to study the neurobiology of behavior. Adv. Genet. 47:2002;1-47.
58. Maskos U., et al. Retrograde trans-synaptic transfer of green fluorescent protein allows the genetic mapping of neuronal circuits in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10120-10125.
59. Miana-Mena F.J., et al. Neuronal activity-dependent membrane traffic at the neuromuscular junction. Proc. Natl. Acad. Sci. U. S. A. 99:2002;3234-3239.
60. Neale E.A., et al. Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal. J. Cell Biol. 147:1999;1249-1260.
61. Brüggemann H., et al. The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc. Natl. Acad. Sci. U. S. A. 100:2003;1316-1321.
62. Rigoni M., et al. Site-directed mutagenesis identifies active-site residues of the light chain of botulinum neurotoxin type A. Biochem. Biophys. Res. Commun. 288:2001;1231-1237.
63. Rossetto O., et al. Active-site mutagenesis of tetanus neurotoxin implicates TYR-375 and GLU-271 in metalloproteolytic activity. Toxicon. 39:2001;1151-1159.
64. Binz T., et al. Arg(362) and Tyr(365) of the botulinum neurotoxin type A light chain are involved in transition state stabilization. Biochemistry. 41:2002;1717-1723.
65. Montecucco C., et al. Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett. 346:1994;92-98.